Global Access
Global Access
IAS 2017: Aim for $90-$90-$90 Target on HIV, Hepatitis, and TB Drug Prices, Study Says
- Details
- Category: HIV Treatment
- Published on Thursday, 17 August 2017 00:00
- Written by Keith Alcorn
HIV, hepatitis B and C, and tuberculosis (TB) can each be treated for less than $90 a year where generic drugs can be made available, Dzintars Gotham of Imperial College London reported at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
IAS 2017: WHO Recommends Urgent Care Package for People with Advanced HIV Disease
- Details
- Category: HIV Treatment
- Published on Wednesday, 09 August 2017 00:00
- Written by Keith Alcorn
A new package of measures to ensure rapid initiation of antiretroviral treatment and diagnosis of opportunistic infections has been recommended by the World Health Organization (WHO) to reduce the still high rates of death among people diagnosed with HIV at a very advanced stage of disease.
CROI 2017: Accelerated Linkage to HIV Care Improves Retention by a Third
- Details
- Category: Global Access
- Published on Thursday, 13 April 2017 00:00
- Written by Carole Leach-Lemens
Close to 60% of adults benefitting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral therapy (ART) initiation, and SMS appointment reminders were retained in care after 1 year, compared to just 44% of those receiving the standard of care in Mozambique, according to findings from the Engage4Health study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle.
IAS 2017: Improved Cryptococcal Meningitis Treatment Could Save Thousands of Lives
- Details
- Category: Opportunistic Illness (OIs)
- Published on Wednesday, 09 August 2017 00:00
- Written by Keith Alcorn
Urgent action is needed to improve access to the antifungal drug flucytosine, say investigators, following the presentation of the results of a trial showing that treatment containing flucytosine is superior to any other form of therapy in reducing the risk of death from cryptococcal meningitis in people with very advanced HIV disease.
CROI 2017: Test and Treat Study Shows Second Phase Is Finding More People with HIV
- Details
- Category: Global Access
- Published on Thursday, 13 April 2017 00:00
- Written by Keith Alcorn
After a second wave of intensive household testing, a large study of the "test and treat" strategy in Zambia is diagnosing more people with HIV, getting more people onto treatment, and reducing the time between diagnosis and starting treatment, findings from the PopART study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) show.
More Articles...
- CROI 2017: Peer Navigators Improve Linkage to HIV Care and Retention in South African Study
- CROI 2017: Point-of-Care Testing Improves Infant HIV Diagnosis Rate, Treatment, and Retention
- Donors Pledge $13 Billion to Replenish Global Fund
- AIDS 2016: Earlier HIV Treatment Is Not Over-burdening Health Services
- AIDS 2016: Infection Prophylaxis Reduces Risk of Death for People Starting HIV Treatment Late
- AIDS 2016: Reducing Clinic Visits Supports Retention in HIV Care, African Studies Show
- AIDS 2016: Study Looks at Comprehensive HIV Treatment and Prevention Services for Sex Workers
- AIDS 2016: Large Test-and-Treat Study Fails to Show Impact on New HIV Infections
- AIDS 2016: Progress Towards 90-90-90 Targets in Southern Africa -- Find the Men!
- CROI 2016: PopART Shows Feasibility of Reaching 90-90-90 HIV Testing and Treatment Targets
- CROI 2016: Botswana Close to Reaching 90-90-90 HIV Testing and Treatment Targets
- CROI 2015: Treatment Cascades and Viral Load Surveys Inform ART as Prevention in Africa
- UNAIDS: HIV Epidemic Will Spring Back without Near-Universal Diagnosis and Treatment
- UNAIDS: "Fast Track" Strategy Could Help End AIDS Epidemic by 2030
- AIDS 2014: Global ART Demand Projected to Reach 16.8 Million by 2016
- UNAIDS Gap Report Finds Half of HIV+ People Worldwide Are Unaware of Status
- CROI 2014: Maternal Deaths Due to HIV Not Declining Despite PMTCT Successes In South Africa
- CROI 2014: Men Not Benefiting as Much as Women from HIV Treatment in Africa [VIDEO]
- Antiretroviral Treatment Has Saved Nearly 3 Million Life-years in South Africa
- World AIDS Day: More Funding for HIV Cure, Global Fund, No One on ADAP Wait List
- UNAIDS Reports Progress Ahead of World AIDS Day
- IAS 2013: Middle-income Countries Outside Africa Pay Four Times More for Antiretroviral Drugs
- UNAIDS: More than 7 Million Africans on HIV Treatment, Deaths Continue to Fall
- CROI 2013: HIV Treatment for Children Safe and Highly Effective without Laboratory Monitoring
- AIDS 2012: Expanded Access to HIV Treatment Lowered AIDS Deaths Worldwide
- AIDS 2012: HIV Drugs Cheaper than Thought, Clinton Report Says
- Death Rates Decline in African Countries Receiving PEPFAR Funding
- CROI 2012: PEPFAR Funding Linked to Lower Death Rate from All Causes in Africa
- UNAIDS Report Shows More People on ART but Funding Loss Threatens Progress
- IAS 2011: HIV Prevention -- A Women's Revolution [VIDEO]
- U.N. AIDS Meeting Calls for More Treatment Access, Fewer Child Infections
- U.N. Report Looks at Global HIV/AIDS Response
- FDA Grants Tentative Approval of Generic Fixed-dose Combination of Efavirenz/emtricitabine/tenofovir
- IAS 2009: Can People in Low-income Countries Benefit from Antiretroviral Therapy without Routine Laboratory Monitoring?
Web Design and Development by